Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Maisha Maliha, MD, a medical resident at NYC Health + Hospitals/Jacobi in the Morris Park section of The Bronx, won the top prize at PAGNY’s 9th Annual Research Day on Wednesday, Nov. 13.

A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Nearly three-quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Lb. Sisters' Tammy Slaton’s next phase in her weight loss journey is skin removal surgery, but her plastic surgeon said it’s ...

Tammy Slaton is hitting an unexpected roadblock on her weight loss journey, as plans for her skin removal surgery face ...

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Niyondiko, N. (2024) Clinical Management of Diabetic Ketoacidosis in Pregnancy: A Review of Current Literature. Open Access Library Journal, 11, 1-25. doi: 10.4236/oalib.1112246 .